LITS
Lite Strategy Inc
NASDAQ · Biotechnology
$1.06
+0.11 (+11.45%)
Open$0.98
Previous Close$0.95
Day High$1.12
Day Low$0.98
52W High$35.26
52W Low$24.56
Volume—
Avg Volume118.4K
Market Cap38.98M
P/E Ratio22.90
EPS$1.29
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,489.6% upside
Current
$1.06
$1.06
Target
$38.05
$38.05
$26.78
$38.05 avg
$46.02
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 12.33M | 11.14M | 10.37M |
| Net Income | -3,474,981 | -2,537,744 | -2,319,778 |
| Profit Margin | -28.2% | -22.8% | -22.4% |
| EBITDA | -5,324,397 | -5,017,327 | -4,875,631 |
| Free Cash Flow | -1,460,004 | -1,340,766 | -1,751,994 |
| Rev Growth | +17.2% | +1.6% | +25.0% |
| Debt/Equity | 0.34 | 0.29 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |